HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Listerine $100 Mil. Spend In 1999 To Include New Tartar Control Mouthwash

This article was originally published in The Rose Sheet

Executive Summary

Warner-Lambert has earmarked $100 mil. to advertise and promote the Listerine brand in 1999, a portion of which will be used to market new Listerine Tartar Control Mouthwash.

You may also be interested in...



W-L Listerine, Lubriderm Sales See Double-Digit Growth In 1999

Listerine mouthwash sales totaled $487 mil. in 1999, a 13% increase, Warner-Lambert announced Jan. 19. The oral care business represented approximately 16% of the company's consumer health care sales, which were up 10% to $3 bil. U.S. consumer health care sales rose 14% to $1.7 bil.

W-L Listerine, Lubriderm Sales See Double-Digit Growth In 1999

Listerine mouthwash sales totaled $487 mil. in 1999, a 13% increase, Warner-Lambert announced Jan. 19. The oral care business represented approximately 16% of the company's consumer health care sales, which were up 10% to $3 bil. U.S. consumer health care sales rose 14% to $1.7 bil.

Warner-Lambert Schick Sales Up 10%, Fueling U.S. Consumer Health Sales

Warner-Lambert Schick shaving system/Wilkinson Sword sales increased 10% to $212 mil. in the third quarter, helping to fuel a double-digit jump in U.S. consumer health care sales.

Latest Headlines
See All
UsernamePublicRestriction

Register

RS006252

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel